Tolaney, Sara M: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

1

Abemaciclib for the treatment of HR+/HER2- breast cancer

Exman, Pedro, Tolaney, Sara M.

Journal:

Expert Review of Precision Medicine and Drug Development

Year:

2018

Language:

english

File:

PDF, 1.08 MB

english, 2018

2

HER2-Low Breast Cancer: Pathological and Clinical Landscape

Tarantino, Paolo, Hamilton, Erika, Tolaney, Sara M., Cortes, Javier, Morganti, Stefania, Ferraro, Emanuela, Marra, Antonio, Viale, Giulia, Trapani, Dario, Cardoso, Fatima, Penault-Llorca, FrÃ©dÃ©rique

Journal:

Journal of Clinical Oncology

Year:

2020

File:

PDF, 727 KB

2020

3

Adjuvant Paclitaxel and Trastuzumab for Node-Negative, HER2-Positive Breast Cancer

Tolaney, Sara M., Barry, William T., Dang, Chau T., Yardley, Denise A., Moy, Beverly, Marcom, P. Kelly, Albain, Kathy S., Rugo, Hope S., Ellis, Matthew, Shapira, Iuliana, Wolff, Antonio C., Carey, Lis

Journal:

New England Journal of Medicine

Year:

2015

Language:

english

File:

PDF, 508 KB

english, 2015

4

De-escalating treatment in the adjuvant setting in HER2-positive breast cancer

Barroso-Sousa, Romualdo, Exman, Pedro, Tolaney, Sara M

Journal:

Future Oncology

Year:

2018

Language:

english

File:

PDF, 1.28 MB

english, 2018

5

Personalized medicine in breast cancer: tamoxifen, endoxifen, and CYP2D6 in clinical practice

Ruddy, Kathryn J., Desantis, Stephen D., Gelman, Rebecca S., Wu, Alan H. B., Punglia, Rinaa S., Mayer, Erica L., Tolaney, Sara M., Winer, Eric P., Partridge, Ann H., Burstein, Harold J.

Journal:

Breast Cancer Research and Treatment

Year:

2013

Language:

english

File:

PDF, 237 KB

english, 2013

6

Sacituzumab Govitecan-hziy in Refractory Metastatic Triple-Negative Breast Cancer

Bardia, Aditya, Mayer, Ingrid A., Vahdat, Linda T., Tolaney, Sara M., Isakoff, Steven J., Diamond, Jennifer R., O’Shaughnessy, Joyce, Moroose, Rebecca L., Santin, Alessandro D., Abramson, Vandana G.,

Journal:

New England Journal of Medicine

Year:

2019

Language:

english

File:

PDF, 311 KB

english, 2019

7

Overcoming Therapeutic Resistance in HER2-Positive Breast Cancers with CDK4/6 Inhibitors

Goel, Shom, Wang, Qi, Watt, April C., Tolaney, Sara M., Dillon, Deborah A., Li, Wei, Ramm, Susanne, Palmer, Adam C., Yuzugullu, Haluk, Varadan, Vinay, Tuck, David, Harris, Lyndsay N., Wong, Kwok-Kin,

Journal:

Year:

2016

Language:

english

File:

PDF, 6.28 MB

english, 2016

8

Effect of Eribulin With or Without Pembrolizumab on Progression-Free Survival for Patients With Hormone ReceptorâPositive, ERBB2 -Negative Metastatic Breast Cancer

Tolaney, Sara M., Barroso-Sousa, Romualdo, Keenan, Tanya, Li, Tianyu, Trippa, Lorenzo, Vaz-Luis, Ines, Wulf, Gerburg, Spring, Laura, Sinclair, Natalie Faye, Andrews, Chelsea, Pittenger, Jessica, Richa

Journal:

Year:

2020

File:

PDF, 363 KB

2020

9

A phase II study of preoperative capecitabine in women with operable hormone receptor positive breast cancer

Tolaney, Sara M., Jeong, Joon, Guo, Hao, Brock, Jane, Morganstern, Daniel, Come, Steven E., Golshan, Mehra, Bellon, Jennifer, Winer, Eric P., Krop, Ian E.

Journal:

Cancer Medicine

Year:

2014

Language:

english

File:

PDF, 459 KB

english, 2014

10

HER2-positive breast cancer: new therapeutic frontiers and overcoming resistance

Pernas, Sonia, Tolaney, Sara M.

Journal:

Therapeutic Advances in Medical Oncology

Year:

2019

Language:

english

File:

PDF, 137 KB

english, 2019

11

Evidence to date: talazoparib in the treatment of breast cancer

Exman, Pedro, Barroso-Sousa, Romualdo, Tolaney, Sara M

Journal:

OncoTargets and Therapy

Year:

2019

Language:

english

File:

PDF, 291 KB

english, 2019

12

Follow-up care of patients with breast cancer

Sara M. Tolaney, Eric P. Winer

Journal:

Year:

2007

Language:

english

File:

PDF, 150 KB

english, 2007

13

Lymphopenia Associated with Adjuvant Anthracycline/Taxane Regimens

Sara M. Tolaney, Julie Najita, Eric P. Winer, Harold J. Burstein

Journal:

Clinical Breast Cancer

Year:

2008

Language:

english

File:

PDF, 110 KB

english, 2008

14

Integrated analysis of RNA and DNA from a phase III trial of trastuzumab-based neoadjuvant chemotherapy identifies response predictors in HER2-positive breast cancer

Tanioka, Maki, Fan, Cheng, Parker, Joel S., Hoadley, Katherine A., Hu, Zhiyuan, Li, Yan, Hyslop, Terry M., Pitcher, Brandelyn N, Soloway, Matthew G, Spears, Patricia A, Henry, N. Lynn, Tolaney, Sara,

Journal:

Clinical Cancer Research

Year:

2018

Language:

english

File:

PDF, 8.74 MB

english, 2018

15

Phase Ib Study of Ribociclib Plus Fulvestrant and Ribociclib Plus Fulvestrant Plus PI3K-Inhibitor (Alpelisib or Buparlisib) for HR+ Advanced Breast Cancer

Tolaney, Sara M, Im, Young-Hyuck, Calvo, Emiliano, Lu, Yen-Shen, Hamilton, Erika P., Forero-Torres, Andres, Bachelot, Thomas, Maur, Michela, Fasolo, Angelica, Tiedt, Ralph, Nardi, Lisa, Stammberger, U

Journal:

Clinical Cancer Research

Year:

2020

File:

PDF, 727 KB

2020

16

Phase I/II study of pilaralisib (SAR245408) in combination with trastuzumab or trastuzumab plus paclitaxel in trastuzumab-refractory HER2-positive metastatic breast cancer

Tolaney, Sara, Burris, Howard, Gartner, Elaina, Mayer, Ingrid A., Saura, Cristina, Maurer, Matthew, Ciruelos, Eva, Garcia, Agustin A., Campana, Frank, Wu, Bin, Xu, Yi, Jiang, Jason, Winer, Eric, Krop,

Journal:

Breast Cancer Research and Treatment

Year:

2015

Language:

english

File:

PDF, 283 KB

english, 2015

17

A phase II trial of cabozantinib in hormoneâreceptor positive breast cancer with bone metastases

Xu, Jing, Higgins, Michaela J., Tolaney, Sara M., Come, Steven E., Smith, Matthew R., Fornier, Monica, Mahmood, Umar, Baselga, Jose, Yeap, Beow Y., Chabner, Bruce A., Isakoff, Steven J.

Journal:

Year:

2020

File:

PDF, 1.31 MB

2020

18

New HER2-Positive Targeting Agents in Clinical Practice

Journal:

Current Oncology Reports

Year:

2014

Language:

english

File:

PDF, 168 KB

english, 2014

19

PD-L1 Testing in Patients with Breast Cancer: Controversies and Current Practice

Exman, Pedro, Garrido-Castro, Ana C., Tolaney, Sara M.

Journal:

Current Breast Cancer Reports

Year:

2019

File:

PDF, 228 KB

2019

20

DeepNeuro: an open-source deep learning toolbox for neuroimaging

Beers, Andrew, Brown, James, Chang, Ken, Hoebel, Katharina, Patel, Jay, Ly, K. Ina, Tolaney, Sara M., Brastianos, Priscilla, Rosen, Bruce, Gerstner, Elizabeth R., Kalpathy-Cramer, Jayashree

Journal:

Neuroinformatics

Year:

2020

File:

PDF, 6.77 MB

2020

21

A Phase I study of DLYE5953A, an anti-LY6E antibody covalently linked to monomethyl auristatin E, in patients with refractory solid tumors

Tolaney, Sara M, Do, Khanh T., Eder, Joseph Paul, LoRusso, Patricia M., Weekes, Colin D., Chandarlaplaty, Sarat, Chang, Ching-Wei, Chen, Shang-Chiung, Nazzal, Denise, Schuth, Eva, Brunstein, Flavia, C

Journal:

Clinical Cancer Research

Year:

2020

File:

PDF, 1.92 MB

2020

22

MONARCH 1, a phase 2 study of abemaciclib, a CDK4 and CDK6 inhibitor, as a single agent, in patients with refractory HR+/HER2- metastatic breast cancer

Dickler, Maura N., Tolaney, Sara, Rugo, Hope S., Cortés, Javier, Dieras, Veronique, Patt, Debra A., Wildiers, Hans, Hudis, Clifford A., O'Shaughnessy, Joyce A., Zamora, Esther, Yardley, Denise, Frenze

Journal:

Clinical Cancer Research

Year:

2017

Language:

english

File:

PDF, 402 KB

english, 2017

23

Incidence of Endocrine Dysfunction Following the Use of Different Immune Checkpoint Inhibitor Regimens

Barroso-Sousa, Romualdo, Barry, William T., Garrido-Castro, Ana C., Hodi, F. Stephen, Min, Le, Krop, Ian E., Tolaney, Sara M.

Journal:

Year:

2017

Language:

english

File:

PDF, 463 KB

english, 2017

24

Open-Label Clinical Trial of Niraparib Combined With Pembrolizumab for Treatment of Advanced or Metastatic Triple-Negative Breast Cancer

Vinayak, Shaveta, Tolaney, Sara M., Schwartzberg, Lee, Mita, Monica, McCann, Georgia, Tan, Antoinette R., Wahner-Hendrickson, Andrea E., Forero, Andres, Anders, Carey, Wulf, Gerburg M., Dillon, Patric

Journal:

Year:

2019

Language:

english

File:

PDF, 434 KB

english, 2019

25

Reply to A.K. Goel et al

Tolaney, Sara M., Winer, Eric P.

Journal:

Journal of Clinical Oncology

Year:

2019

Language:

english

File:

PDF, 451 KB

english, 2019

26

A Phase 1 trial of the poly(ADP-ribose) polymerase inhibitor olaparib (AZD2281) in combination with the anti-angiogenic cediranib (AZD2171) in recurrent epithelial ovarian or triple-negative breast cancer

Liu, Joyce F., Tolaney, Sara M., Birrer, Michael, Fleming, Gini F., Buss, Mary K., Dahlberg, Suzanne E., Lee, Hang, Whalen, Christin, Tyburski, Karin, Winer, Eric, Ivy, Percy, Matulonis, Ursula A.

Journal:

European Journal of Cancer

Year:

2013

Language:

english

File:

PDF, 580 KB

english, 2013

27

Endocrine dysfunction induced by immune checkpoint inhibitors: Practical recommendations for diagnosis and clinical management

Barroso-Sousa, Romualdo, Ott, Patrick A., Hodi, F. Stephen, Kaiser, Ursula B., Tolaney, Sara M., Min, Le

Journal:

Year:

2018

Language:

english

File:

PDF, 452 KB

english, 2018

28

Phase II study of tivantinib (ARQ 197) in patients with metastatic triple-negative breast cancer

Tolaney, Sara M., Tan, Sally, Guo, Hao, Barry, William, Van Allen, Eliezer, Wagle, Nikhil, Brock, Jane, Larrabee, Katherine, Paweletz, Cloud, Ivanova, Elena, Janne, Pasi, Overmoyer, Beth, Wright, John

Journal:

Investigational New Drugs

Year:

2015

Language:

english

File:

PDF, 786 KB

english, 2015

29

Phase I/II dose-escalation study of PI3K inhibitors pilaralisib or voxtalisib in combination with letrozole in patients with hormone-receptor-positive and HER2-negative metastatic breast cancer refractory to a non-steroidal aromatase inhibitor

Blackwell, Kimberly, Burris, Howard, Gomez, Patricia, Lynn Henry, N., Isakoff, Steven, Campana, Frank, Gao, Lei, Jiang, Jason, Macé, Sandrine, Tolaney, Sara M.

Journal:

Breast Cancer Research and Treatment

Year:

2015

Language:

english

File:

PDF, 503 KB

english, 2015

30

Role of vascular density and normalization in response to neoadjuvant bevacizumab and chemotherapy in breast cancer patients

Tolaney, Sara M., Boucher, Yves, Duda, Dan G., Martin, John D., Seano, Giorgio, Ancukiewicz, Marek, Barry, William T., Goel, Shom, Lahdenrata, Johanna, Isakoff, Steven J., Yeh, Eren D., Jain, Saloni R

Journal:

Proceedings of the National Academy of Sciences

Year:

2015

Language:

english

File:

PDF, 871 KB

english, 2015

31

Cabozantinib for metastatic breast carcinoma: results of a phase II placebo-controlled randomized discontinuation study

Tolaney, Sara M., Nechushtan, Hovav, Ron, Ilan-Gil, Schöffski, Patrick, Awada, Ahmad, Yasenchak, Chris A., Laird, A. Douglas, O’Keeffe, Bridget, Shapiro, Geoffrey I., Winer, Eric P.

Journal:

Breast Cancer Research and Treatment

Year:

2016

Language:

english

File:

PDF, 516 KB

english, 2016

32

TROPiCS-02: A Phase III study investigating sacituzumab govitecan in the treatment of HR+/HER2- metastatic breast cancer

Rugo, Hope S, Bardia, Aditya, Tolaney, Sara M, Arteaga, Carlos, Cortes, Javier, Sohn, Joohyuk, MarmÃ©, Frederik, Hong, Quan, Delaney, Rosemary J, Hafeez, Amir, AndrÃ©, Fabrice, Schmid, Peter

Journal:

Future Oncology

Year:

2020

File:

PDF, 4.47 MB

2020

33

The Impact of COVID-19 on Clinical Trial Execution at the Dana-Farber Cancer Institute

Tolaney, Sara M, Lydon, Christine A, Li, Tianyu, Dai, Jiale, Standring, Andrea, Legor, Kristen A, Caparrotta, Caryn M, Schenker, Matthew P, Glazer, Daniel I, Tayob, Nabihah, DuBois, Steven G, Meyerhar

Journal:

JNCI Journal of the National Cancer Institute

Year:

2020

File:

PDF, 813 KB

2020

34

Database Selection and Heterogeneity—More Details, More Credibility—Reply

Barroso-Sousa, Romualdo, Barry, William T., Tolaney, Sara M.

Journal:

Year:

2018

Language:

english

File:

PDF, 39 KB

english, 2018

35

Clinical Development of PD-1/PD-L1 Inhibitors in Breast Cancer: Still a Long Way to Go

Barroso-Sousa, Romualdo, Tolaney, Sara M.

Journal:

Current Treatment Options in Oncology

Year:

2020

File:

PDF, 382 KB

2020

36

SPS-3A prognostic model integrating clinical data and gene signatures in phase III neoadjuvant trial CALGB 40601 (Alliance)

Tanioka, Maki, Parker, Joel S, Henry, Lynn N, Tolaney, Sara, Dang, Chau, Krop, Ian E, Harris, Lyndsay, Hillman, David, Polley, Mei, Berry, Donald A, Winer, Eric P, Carey, Lisa A, Perou, Charles M

Journal:

Annals of Oncology

Year:

2018

Language:

english

File:

PDF, 94 KB

english, 2018

37

SPS-3A prognostic model integrating clinical data and gene signatures in phase III neoadjuvant trial CALGB 40601 (Alliance)

Tanioka, Maki, Parker, Joel S, Henry, Lynn N, Tolaney, Sara, Dang, Chau, Krop, Ian E, Harris, Lyndsay, Hillman, David, Polley, Mei, Berry, Donald A, Winer, Eric P, Carey, Lisa A, Perou, Charles M

Journal:

Annals of Oncology

Year:

2018

File:

PDF, 94 KB

2018

38

Sarcoidosis Mimicking Metastatic Breast Cancer

Sara M. Tolaney, Yolanda L. Colson, Ritu R. Gill, Stephanie Schulte, Margaret M. Duggan, Lawrence N. Shulman, Eric P. Winer

Journal:

Clinical Breast Cancer

Year:

2007

Language:

english

File:

PDF, 2.47 MB

english, 2007

39

Phase Ib Study of Safety and Pharmacokinetics of the PI3K Inhibitor SAR245408 with the HER3-Neutralizing Human Antibody SAR256212 in Patients with Solid Tumors

Abramson, Vandana G., Supko, Jeffrey G., Ballinger, Tarah, Cleary, James M., Hilton, John F., Tolaney, Sara M., Chau, Nicole G., Cho, Daniel C., Pearlberg, Joseph, Lager, Joanne, Shapiro, Geoffrey I.,

Journal:

Clinical Cancer Research

Year:

2016

Language:

english

File:

PDF, 443 KB

english, 2016

40

Neoadjuvant bevacizumab: surgical complications of mastectomy with and without reconstruction

Kansal, Kari Joanne, Dominici, Laura Stewart, Tolaney, Sara M., Isakoff, Steven J., Smith, Barbara L., Jiang, Wei, Brock, Jane E., Winer, Eric P., Krop, Ian E., Golshan, Mehra

Journal:

Breast Cancer Research and Treatment

Year:

2013

Language:

english

File:

PDF, 161 KB

english, 2013

41

A phase 1 study combining the HER3 antibody seribantumab (MM-121) and cetuximab with and without irinotecan

Cleary, James M., McRee, Autumn J., Shapiro, Geoffrey I., Tolaney, Sara M., O’Neil, Bert H., Kearns, Jeffrey D., Mathews, Sara, Nering, Rachel, MacBeath, Gavin, Czibere, Akos, Sharma, Sunil, Korn, W.

Journal:

Investigational New Drugs

Year:

2017

Language:

english

File:

PDF, 861 KB

english, 2017

42

Occurrence and significance of morphologic changes in patients with metastatic triple negative breast cancer treated with Cabozantinib

Shinagare, Atul B., Somarouthu, Bhanusupriya, Guo, Hao, Tolaney, Sara M., Ramaiya, Nikhil H.

Journal:

Clinical Imaging

Year:

2018

Language:

english

File:

PDF, 359 KB

english, 2018

43

Integration of Physician and Nursing Professional Efforts to Deliver Supportive Scalp Cooling Care to Oncology Patients at Risk for Alopecia

Peterson, Lindsay L., Lustberg, Maryam, Tolaney, Sara M., Ross, Mikel, Salehi, Elahe, Isakoff, Steven J.

Journal:

Oncology and Therapy

Year:

2020

File:

PDF, 791 KB

2020

44

NIMG-63. ADVANCED IMAGING FOR ASSESSING VOLUMETRIC RESPONSES IN BRAIN METASTASES TREATED WITH CHECKPOINT BLOCKADE

Gerstner, Elizabeth, Cardona, Jonathan, Chang, Ken, Beers, Andrew, Brown, James, Kalpathy-Cramer, Jayashree, Lee, Eudocia, Lin, Nancy, Tolaney, Sara, Nayak, Lakshmi, Chukwueke, Ugonma, Oh, Kevin, Shih

Journal:

Year:

2018

Language:

english

File:

PDF, 84 KB

english, 2018

45

CDK4/6 inhibitors in breast cancer: a role in triple-negative disease?

Goel, Shom, Tolaney, Sara M

Journal:

The Lancet Oncology

Year:

2019

File:

PDF, 138 KB

2019

46

P2.06-012 Phase 2 Study of Abemaciclib + Pembrolizumab in KRAS Mutation, PD-L1+, Stage IV Non-Small Cell or Squamous Cell Lung Cancer

Mazieres, Julien, Tolaney, Sara, Paz-Ares, Luis, Pujol, Jean-Louis, Goksel, Tuncay, Lin, Chia-Chi, Hossain, Anwar, John, William, Kabos, Peter

Journal:

Journal of Thoracic Oncology

Year:

2017

Language:

english

File:

PDF, 144 KB

english, 2017

47

Characterization of Thyroid Disorders in Patients Receiving Immune Checkpoint Inhibition Therapy

Lee, Hyunju, Hodi, F. Stephen, Giobbie-Hurder, Anita, Ott, Patrick A., Buchbinder, Elizabeth I., Haq, Rizwan, Tolaney, Sara, Barroso-Sousa, Romualdo, Zhang, Kevin, Donahue, Hilary, Davis, Meredith, Ga

Journal:

Cancer Immunology Research

Year:

2017

Language:

english

File:

PDF, 1.04 MB

english, 2017

48

Optimal treatment of early stage HER2-positive breast cancer

Pernas, Sonia, Barroso-Sousa, Romualdo, Tolaney, Sara M.

Journal:

Year:

2018

Language:

english

File:

PDF, 614 KB

english, 2018

49

CDK4/6 inhibitors in breast cancer: a role in triple-negative disease?

Goel, Shom, Tolaney, Sara M

Journal:

The Lancet Oncology

Year:

2019

Language:

english

File:

PDF, 138 KB

english, 2019

50

Survival, Pathologic Response, and Genomics in CALGB 40601 (Alliance), a Neoadjuvant Phase III Trial of Paclitaxel-Trastuzumab With or Without Lapatinib in HER2-Positive Breast Cancer

Fernandez-Martinez, Aranzazu, Krop, Ian E., Hillman, David W., Polley, Mei-Yin, Parker, Joel S., Huebner, Lucas, Hoadley, Katherine A., Shepherd, Jonathan, Tolaney, Sara, Henry, N. Lynn, Dang, Chau, H

Journal:

Journal of Clinical Oncology

Year:

2020

File:

PDF, 769 KB

2020

To build up a library is to create a life. It’s never just a random collection of books.

— Carlos María Domínguez

Official channel

Z-Library Desktop Launcher

Z-Library Since 2009 support@1delivery.pm

EnglishРусскийEspañolItalianoελληνικάاللغة العربيةBahasa IndonesiaBahasa Malaysiaहिन्दीDeutschFrançaisPortuguêsУкраїнськаPolski中文繁體中文日本語Tiếng ViệtAzərbaycan DiliՀայոց լեզուภาษาไทยTürk Diliქართველიবাংলাپښتوతెలుగుاردو한국어SrpskiБългарски